Prevalence of Carriers of Intermediate and Pathological Polyglutamine Disease–Associated Alleles Among Large Population-Based Cohorts

Sarah L. Gardiner(Leiden University Medical Center), N. Ahmad Aziz(University of Bonn), Frits R. Rosendaal(Leiden University Medical Center), Merel W. Boogaard(Erasmus MC), Stella Trompet, Renée de Mutsert(Leiden University Medical Center), J. Wouter Jukema(Leiden University Medical Center), Raymund A.C. Roos(Leiden University Medical Center), Jacobijn Gussekloo(Leiden University Medical Center)
JAMA Neurology
April 1, 2019
10.1001/jamaneurol.2019.0423
Cited by 102

Related Papers

Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome
|New England Journal of Medicine|2018|3.5k
Incidence and mortality of venous thrombosis: a population‐based study
|Journal of Thrombosis and Haemostasis|2007|1.4k
Preoperative anaemia and postoperative outcomes in non-cardiac surgery: a retrospective cohort study
|The Lancet|2011|1.3k
Subclinical Hypothyroidism and the Risk of Coronary Heart Disease and Mortality
|JAMA|2010|1.2k
World Health Organization cardiovascular disease risk charts: revised models to estimate risk in 21 global regions
|The Lancet Global Health|2019|1.2k